QUIZARTINIB for Leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where QUIZARTINIB was used for Leukaemia.
Most Reported Side Effects for QUIZARTINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 47 | 13.2% | 2 | 3 |
| No adverse event | 40 | 11.2% | 0 | 0 |
| Death | 32 | 9.0% | 32 | 5 |
| Platelet count decreased | 27 | 7.6% | 5 | 12 |
| Nausea | 25 | 7.0% | 2 | 8 |
| Disease progression | 20 | 5.6% | 8 | 6 |
| Pyrexia | 20 | 5.6% | 1 | 15 |
| Electrocardiogram qt prolonged | 19 | 5.3% | 3 | 4 |
| Febrile neutropenia | 19 | 5.3% | 4 | 12 |
| Product dose omission issue | 18 | 5.0% | 1 | 7 |
| Infection | 17 | 4.8% | 4 | 11 |
| Pneumonia | 16 | 4.5% | 5 | 11 |
| Fatigue | 14 | 3.9% | 0 | 5 |
| Therapy change | 13 | 3.6% | 1 | 3 |
| Asthenia | 12 | 3.4% | 0 | 7 |
Other Indications for QUIZARTINIB
Acute myeloid leukaemia (274)
Product used for unknown indication (37)
Acute leukaemia (15)
Acute myeloid leukaemia (in remission) (5)
Acute myelomonocytic leukaemia (5)
Other Drugs Used for Leukaemia
DASATINIB (654)
VENETOCLAX (307)
CYTARABINE (288)
METHOTREXATE (282)
IMATINIB (281)
RUXOLITINIB (230)
NILOTINIB (203)
BOSUTINIB (191)
VINCRISTINE (172)
CYCLOPHOSPHAMIDE (153)